Corporate Profile for Schwarz Pharma, Inc., dated Oct. 1, 1999.--(BUSINESS WIRE)-- The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: Oct. 1, 1999
Company Name: Schwarz Pharma, Inc.
Address: 6140 West Executive Drive
Mequon, WI 53092
Main Telephone
Number: 800-558-5114
Internet Home
Page Address
(URL) www.schwarzusa.com
Chief Executive
Officer: Dr. Klaus Veitinger
Chief Financial
Officer: Richard Losiniecki
Investor Relations
Contact: Public Relations Manager
Business number: 262-238-5704
E-mail address: prmgr@schwarzusa.com
Public Relations
Contact: Public Relations Manager
Business number: 262-238-5704
E-mail address: prmgr@schwarzusa.com
Industry: Pharmaceutical
Company description: Schwarz Schwarz is a common surname, derived from the German schwarz, meaning black. It may refer to: People
Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented. , gastroenterology gastroenterology Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833. , urology urology Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. and neurology neurology (n  rŏl`əjē, ny–), study of the morphology, physiology, and pathology of the human nervous system. , Schwarz
Pharma is dedicated to the global search and development of new drug
therapies in areas that address unmet un·met adj. Not satisfied or fulfilled: unmet demands. medical needs. Schwarz Pharma has licensing agreements in 50 countries and posted consolidated sales of DM1.33 billion in 1998, a 4.8% increase over the previous year. The U.S. business expanded by 18% and was a major contributor in the overall growth of the international business. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion